SCHEMBL5699570

SCHEMBL5699570

CCCCOC(=O)NC(O)(CCc1ccccc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.49
CTSK P43235 2/20 0.48
TDP1 Q9NUW8 3/20 0.48
TSHR P16473 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAPK1 P28482 1/20 0.48
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
RECQL P46063 1/20 0.47
POLB P06746 1/20 0.46
GLS O94925 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6602876 0.87 POLB (0.41) GAACTSKTDP1TSHRL3MBTL1
SCHEMBL290981 0.87 TDP1 (0.50) GAACTSKTDP1TSHRL3MBTL1
Water SCHEMBL2946569 0.86 TDP1 (0.49) GAACTSKTDP1TSHRL3MBTL1
SCHEMBL8442319 0.84 KMT2A (0.53) TDP1L3MBTL1ALDH1A1MAPK1NPC1
SCHEMBL8442388 0.84 KMT2A (0.53) TDP1L3MBTL1ALDH1A1MAPK1NPC1
SCHEMBL5774552 0.82 EPHX1 (0.43) ALDH1A1SMN1; SMN2POLBCYP1A2CYP2C19
Hexane SCHEMBL28121925 0.79 CTSK (0.45) CTSKALDH1A1RECQL
SCHEMBL8951255 0.79 CA12 (0.50) CTSKNPC1RAB9A
SCHEMBL9218191 0.79 CA12 (0.50) CTSKNPC1RAB9A
SCHEMBL6342947 0.79 CA12 (0.50) CTSKNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925746-A1 SUBSTITUTED TRIAZOLE AND IMIDAZOLE COMPOUNDS F. Hoffmann-La Roche AG (CH) 2015-10-07 EP disclosed
EP-2906581-A1 KETOAMIDE IMMUNOPROTEASOME INHIBITORS F. Hoffmann-La Roche AG (CH) 2015-08-19 EP disclosed
EP-2906582-A1 MACROCYCLIC KETOAMIDE IMMUNOPROTEASOME INHIBITORS F. Hoffmann-La Roche AG (CH) 2015-08-19 EP disclosed
WO-2014086663-A1 SUBSTITUTED TRIAZOLE AND IMIDAZOLE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2014-06-12 WO disclosed
WO-2014056748-A1 KETOAMIDE IMMUNOPROTEASOME INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2014-04-17 WO disclosed
WO-2014056954-A1 MACROCYCLIC KETOAMIDE IMMUNOPROTEASOME INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2014-04-17 WO disclosed
EP-1713470-A1 THERAPEUTIC COMBINATIONS Pfizer, Inc. (US) 2006-10-25 EP disclosed
EP-1713478-A1 COMPOSITIONS COMPRISING HIV PROTEASE INHIBITOR AND CYTOCHROME P450 ENZYME ACTIVITY INHIBITOR PFIZER INC. (US) 2006-10-25 EP disclosed
EP-1694657-A1 COMPOSITIONS COMPRISING AN HIV PROTEASE INHIBITOR PFIZER INC. (US) 2006-08-30 EP disclosed
EP-1692119-A1 METHODS OF PREPARING COMPOUNDS USEFUL AS PROTEASE INHIBITORS PFIZER INC. (US) 2006-08-23 EP disclosed
WO-2005082364-A1 COMPOSITIONS COMPRISING HIV PROTEASE INHIBITOR AND CYTOCHROME P450 ENZYME ACTIVITY INHIBITOR PFIZER INC. (US) 2005-09-09 WO disclosed
WO-2005082362-A1 THERAPEUTIC COMBINATIONS PFIZER INC. (US) 2005-09-09 WO disclosed
WO-2005056542-A1 COMPOSITIONS COMPRISING AN HIV PROTEASE INHIBITOR PFIZER INC. (US) 2005-06-23 WO disclosed
WO-2005054214-A1 METHODS OF PREPARING COMPOUNDS USEFUL AS PROTEASE INHIBITORS PFIZER INC. (US) 2005-06-16 WO disclosed
EP-0832066-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL-) AMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1998-04-01 EP disclosed
WO-1996039385-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL-) AMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1996-12-12 WO disclosed